Xometry [XMTR] vs GE Vernova [GEV] Detailed Stock Comparison
Xometry
NASDAQ
Loading...
GE Vernova
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Xometry wins in 6 metrics, GE Vernova wins in 11 metrics, with 0 ties. GE Vernova appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Xometry | GE Vernova | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -43.23 | 146.04 | Xometry |
| Price-to-Book Ratio | 8.26 | 18.50 | Xometry |
| Debt-to-Equity Ratio | 123.35 | 10.65 | GE Vernova |
| PEG Ratio | -0.50 | -2.44 | GE Vernova |
| EV/EBITDA | -77.08 | 68.12 | Xometry |
| Profit Margin (TTM) | -10.20% | 3.16% | GE Vernova |
| Operating Margin (TTM) | -6.27% | 5.92% | GE Vernova |
| EBITDA Margin (TTM) | N/A | 5.92% | N/A |
| Return on Equity | -20.94% | 11.41% | GE Vernova |
| Return on Assets (TTM) | -4.29% | 1.79% | GE Vernova |
| Free Cash Flow (TTM) | $-33.48M | $1.70B | GE Vernova |
| Dividend Yield | N/A | 0.05% | N/A |
| 1-Year Return | 130.77% | 230.62% | GE Vernova |
| Price-to-Sales Ratio (TTM) | 3.71 | 4.48 | Xometry |
| Enterprise Value | $2.43B | $164.78B | GE Vernova |
| EV/Revenue Ratio | 4.03 | 4.50 | Xometry |
| Gross Profit Margin (TTM) | 40.10% | 20.26% | Xometry |
| Revenue per Share (TTM) | $12 | $133 | GE Vernova |
| Earnings per Share (Diluted) | $-1.23 | $4.13 | GE Vernova |
| Beta (Stock Volatility) | 0.83 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Xometry vs GE Vernova Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Xometry | 5.80% | -1.29% | 33.82% | 39.10% | 44.31% | 11.87% |
| GE Vernova | 0.17% | -3.08% | 7.08% | 33.77% | 84.82% | 78.79% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Xometry | 130.77% | 0.69% | -32.97% | -32.97% | -32.97% | -32.97% |
| GE Vernova | 230.62% | 393.89% | 393.89% | 393.89% | 393.89% | 393.89% |
Performance & Financial Health Analysis: Xometry vs GE Vernova
| Metric | XMTR | GEV |
|---|---|---|
| Market Information | ||
| Market Cap | $2.24B | $164.19B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 711,411 | 2,320,568 |
| 90 Day Avg. Volume | 886,660 | 2,724,486 |
| Last Close | $49.27 | $607.03 |
| 52 Week Range | $16.11 - $49.50 | $173.07 - $677.29 |
| % from 52W High | -0.46% | -10.37% |
| All-Time High | $97.57 (Jun 28, 2021) | $677.29 (Jul 31, 2025) |
| % from All-Time High | -49.50% | -10.37% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.23% | 0.11% |
| Quarterly Earnings Growth | 0.23% | -0.60% |
| Financial Health | ||
| Profit Margin (TTM) | -0.10% | 0.03% |
| Operating Margin (TTM) | -0.06% | 0.06% |
| Return on Equity (TTM) | -0.21% | 0.11% |
| Debt to Equity (MRQ) | 123.35 | 10.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.35 | $32.61 |
| Cash per Share (MRQ) | $4.45 | $27.52 |
| Operating Cash Flow (TTM) | $1.33M | $3.58B |
| Levered Free Cash Flow (TTM) | $-6,709,750 | $3.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.05% |
| Last 12-Month Dividend | N/A | $0.25 |
Valuation & Enterprise Metrics Analysis: Xometry vs GE Vernova
| Metric | XMTR | GEV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -43.23 | 146.04 |
| Forward P/E | 157.68 | 87.41 |
| PEG Ratio | -0.50 | -2.44 |
| Price to Sales (TTM) | 3.71 | 4.48 |
| Price to Book (MRQ) | 8.26 | 18.50 |
| Market Capitalization | ||
| Market Capitalization | $2.24B | $164.19B |
| Enterprise Value | $2.43B | $164.78B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.03 | 4.50 |
| Enterprise to EBITDA | -77.08 | 68.12 |
| Risk & Other Metrics | ||
| Beta | 0.83 | N/A |
| Book Value per Share (MRQ) | $5.35 | $32.61 |
Financial Statements Comparison: Xometry vs GE Vernova
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | XMTR | GEV |
|---|---|---|
| Revenue/Sales | $150.97M | $8.03B |
| Cost of Goods Sold | $94.64M | $6.56B |
| Gross Profit | $56.33M | $1.47B |
| Research & Development | $11.17M | $239.00M |
| Operating Income (EBIT) | $-15.39M | $43.00M |
| EBITDA | $-9.64M | $225.00M |
| Pre-Tax Income | $-15.08M | $332.00M |
| Income Tax | $0 | $68.00M |
| Net Income (Profit) | $-15.08M | $264.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | XMTR | GEV |
|---|---|---|
| Cash & Equivalents | $15.51M | $8.11B |
| Total Current Assets | $334.62M | $33.94B |
| Total Current Liabilities | $89.43M | $32.68B |
| Long-Term Debt | $288.62M | N/A |
| Total Shareholders Equity | $311.03M | $9.67B |
| Retained Earnings | $-385.35M | $1.87B |
| Property, Plant & Equipment | $13.87M | $13.11B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | XMTR | GEV |
|---|---|---|
| Operating Cash Flow | $-21.87M | $1.56B |
| Capital Expenditures | $-6.96M | $-152.00M |
| Free Cash Flow | $-7.39M | $975.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-1.10B |
Short Interest & Institutional Ownership Analysis
| Metric | XMTR | GEV |
|---|---|---|
| Shares Short | 5.69M | 6.80M |
| Short Ratio | 9.63 | 2.23 |
| Short % of Float | 0.14% | 0.03% |
| Average Daily Volume (10 Day) | 711,411 | 2,320,568 |
| Average Daily Volume (90 Day) | 886,660 | 2,724,486 |
| Shares Outstanding | 49.76M | 275.65M |
| Float Shares | 43.54M | 271.79M |
| % Held by Insiders | 0.12% | 0.00% |
| % Held by Institutions | 1.02% | 0.79% |
Dividend Analysis & Yield Comparison: Xometry vs GE Vernova
| Metric | XMTR | GEV |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.25 |
| Last 12-Month Dividend Yield | N/A | 0.05% |
| 3-Year Avg Annual Dividend | N/A | $0.08 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $0.25 |
| Ex-Dividend Date | N/A | Dec 20, 2024 |